F-18 Fludeoxyglucose Unit Dose radiopharmaceuticals

The contract is a pre-solicitation sources sought notice for the supply of approximately 450 FDA-approved F-18 Fludeoxyglucose (FDG) unit dose radiopharmaceuticals to the Dwight David Eisenhower Army Medical Center’s Nuclear Medicine Department at Fort Gordon, Georgia. The contractor must be an FDA-approved radioisotope provider capable of producing, packaging, and delivering 10–15 mCi unit doses no less than 30 minutes prior to calibration time at the medical center, ensuring timely usability given the isotope’s 110-minute half-life. All personnel, equipment, transportation, materials, and non-personal services required for production and delivery are the contractor’s responsibility, with the exception of any government-furnished property. The contract is anticipated to be a firm fixed-price arrangement under NAICS code 325412, which defines small business size standards at 1,300 employees. Submissions must be made via email to the designated point of contact, Wayne Shavers, by the deadline of May 7, 2026, in the form of a five-page Statement of Capability that includes the offeror’s business information, expression of interest, proof of FDA approval, demonstration of delivery capability, and socioeconomic status if applicable. Offerors must be registered in SAM.gov with a valid Unique Entity ID and CAGE code; subcontracting is not anticipated. No formal contract clauses, evaluation factors, pricing details, or delivery milestones are included, as this document serves only as a market research tool to assess industry capability and readiness. The government retains the right to award or not award a contract based on responses received, and no reimbursement will be provided for proposal preparation costs. Delivery performance is strictly tied to the operational schedule of the medical center, requiring reliable, high-frequency logistics aligned with diagnostic imaging procedures.